Intranasal formulation of rotigotine

Details for Australian Patent Application No. 2004308641 (hide)

International Classifications

Event Publications

8 September 2005 PCT application entered the National Phase

PCT publication WO2005/063236 Priority application(s): WO2005/063236

26 October 2006 Application Accepted

Published as AU-B-2004308641

1 March 2007 Standard Patent Sealed

16 December 2010 Alteration of Name

The name of the patentee has been altered to UCB Pharma GmbH 2005

19 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.